Health
Clawback Tax Could Drop To 5% As Drug Prices Are Lowered
The clawback tax could drop to 5%, as prices of medicines are lowered, health Insurance House president Vasile Ciurchea said Tuesday.
Romanian Pharmaceutical Sales Rose 10.7% In 1Q
Sales of medicines in Romania stood at RON3.27 billion in the first quarter, considering distribution prices, up 10.7% on the year, according to Cegedim's Pharma & Hospital Report report.
Advent International Expects Non-Binding Bids For Regina Maria This Week
Private equity fund Advent International is expecting non-binding offers for the majority stake in private medical service provider Regina Maria, the only business it has left in Romania.
Zentiva Romania Sees Lower Profit In First Quarter
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported net profit of 12 million lei (EUR2.7 million) for the first quarter of 2015, down 15.5% compared with RON...
Ropharma Posts 15% Increase In 1Q Net Profit
Romanian pharmaceutical company Ropharma (RPH.RO) posted a 15% rise in its first-quarter net profit, fueled by a similar increase in operating income.
Biofarm Reports 37% Higher Net Profit in 1Q
Romanian medicine producer Biofarm (BIO.RO) reported a net profit of 13.6 million lei (EUR3 million) for the first quarter, up 37.3% from the year earlier period, on higher sales.
Antibiotice 1Q Net Profit Up 15% To RON6M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit of 6 million lei (EUR1.4 million) for the first quarter, up 15% on the year, the company said in a statement Frid...
Investment Fund Mezzanine Becomes Shareholder Of Amethyst Radiotherapy
Investment fund Accession Mezzanine Capital III, managed by Mezzanine Management, has entered the shareholding structure of radiotherapy centers Amethyst Radiotherapy Limited, following a ca...
Eleven Investors Interested To Buy Minority Stake In MedLife
A number of eleven investors have expressed their interest to take over a minority stake in Romanian private healthcare provider MedLife during the first stage of discussions, but there are...